Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
PODCAST | First void urine: revolutionizing potential non-invasive biomarker collection for clinical diagnostics LISTEN NOW

Video: Antibody drug–conjugates characterization (Waters Corporation)

21 May 2015
Chromatography MS (LC–MS/MS, HRMS, IMS)

This video discusses powerful analytical tools which can be used to interrogate and understand ADCs. In particular, it outlines:

  • Characterizing ADCs with hydrophobic interaction chromatography
  • Deriving DAR via native UPLC/MS
  • Resolving positional isomers by 2D UPLC/MS
  • Identifying conjugation by peptide mapping

Top content

  • Flow cytometry at 60: will the diamond endure?
  • The bioanalysis Christmas personality quiz
  • The results are in: hybridization LC–MS vs LBA for oligonucleotide bioanalysis

Related tags

ADCs LC-MS MS
Previous article Next article

Related articles

16 MAR 2016 CLINICAL
Multiple stage MS in analysis of plasma, serum, urine and in vitro samples relevant to clinical and forensic toxicology
22 MAR 2011 CHROMATOGRAPHY
Interview with Dr Stuart Best on his new appointment at Xceleron
"Several green and yellow antibodies scattered randomly across a turquoise background."
11 DEC 2024 AN AUTHOR'S PERSPECTIVE
An author’s perspective: Rachel Foreman on optimized LC-MS/MS methods for quantifying ADC payloads
18 JUN 2013 INTERVIEWS
Interview with Mike Oliver on sample preparation method optimization for increased efficiency in bioanalytical workflows
16 MAR 2023 INTERVIEWS
Human vs. machine: Neil Spooner takes on ChatGPT
31 MAY 2009 CHROMATOGRAPHY
Ion suppression and cannulation locking solutions
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone